TickerLeague

EBITDA for Medtronic (MDT)

According to Medtronic's latest reported financial statements, the company's current EBITDA (TTM) is $9.36B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$9.36B

YoY change

+12.4%

5Y CAGR

+3.4%

Peak year (2018)

$9.46B

Cumulative EBITDA

$157.67B

EBITDA history chart for Medtronic (MDT) from 1986 to 2025

EBITDA history table for Medtronic (MDT) from 1986 to 2025

Fiscal yearPeriod endedReportedEBITDAYoY
2025$9.22B+12.4%
2024$8.20B-5.7%
2023$8.70B-0.9%
2022$8.78B+16.7%
2021$7.52B-3.7%
2020$7.81B-16.0%
2019$9.30B-1.7%
2018$9.46B+9.9%
2017$8.61B+0.8%
2016$8.54B+56.5%
2015$5.46B+10.6%
2014$4.93B-9.6%
2013$5.46B+2.5%
2012$5.33B+8.3%
2011$4.92B-3.9%
2010$5.12B+45.8%
2009$3.51B-7.1%
2008$3.78B-12.6%
2007$4.32B+1.7%
2006$4.25B+8.8%
2005$3.91B+7.8%
2004$3.62B+18.4%
2003$3.06B+23.5%
2002$2.48B+13.9%
2001$2.18B+12.9%
2000$1.93B+22.0%
1999$1.58B+25.5%
1998$1.26B+20.4%
1997$1.05B+39.7%
1996$748.00M+37.8%
1995$542.80M+32.0%
1994$411.20M+12.8%
1993$364.70M+19.4%
1992$305.40M+20.8%
1991$252.90M+23.7%
1990$204.40M+17.3%
1989$174.30M+9.6%
1988$159.10M+20.4%
1987$132.10M+32.6%
1986$99.60M

EBITDA values are taken from Medtronic's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, Medtronic (MDT) reported EBITDA of $9.22B – grew 12.4% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Medtronic EBITDA compounded at +3.4% per year, with the latest reading among the more recent periods of the dataset.

Medtronic EBITDA edged down from $9.46B in 2018 to $9.22B in 2025, a 2.6% drawdown.

The highest annual EBITDA of $9.46B was reported in 2018. The lowest in the available history was $99.60M in 1986.

Medtronic (MDT) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.

Medtronic EBITDA by Year

Medtronic EBITDA 2025: $9.22B

Medtronic EBITDA in 2025 was $9.22B, grew 12.4% from 2024.

Medtronic EBITDA 2024: $8.20B

Medtronic EBITDA in 2024 was $8.20B, declined 5.7% below 2023.

Medtronic EBITDA 2023: $8.70B

Medtronic EBITDA in 2023 was $8.70B, edged down 0.9% below 2022.

Medtronic EBITDA 2022: $8.78B

Medtronic EBITDA in 2022 was $8.78B, grew 16.7% from 2021.

Medtronic EBITDA 2021: $7.52B

Medtronic EBITDA in 2021 was $7.52B.

See more financial history for Medtronic (MDT).

Sector peers — EBITDA

Companies in the same sector as Medtronic, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk A/S (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Eli Lilly and Company (LLY)$27.94BHealthcare
Merck & Co., Inc. (MRK)$25.36BHealthcare
UnitedHealth Group Incorporated (UNH)$23.06BHealthcare
AstraZeneca PLC (AZN)$19.83BHealthcare
AbbVie Inc. (ABBV)$17.63BHealthcare
Amgen Inc. (AMGN)$15.84BHealthcare

Frequently asked questions

What is Medtronic's EBITDA?

Latest reported EBITDA for Medtronic (MDT) is $9.36B (period ending January 23, 2026).

How has Medtronic EBITDA changed year-over-year?

Medtronic (MDT) EBITDA changed +12.4% year-over-year on the latest annual filing.

What is the long-term growth rate of Medtronic EBITDA?

Medtronic (MDT) EBITDA compound annual growth rate is +3.4% over the most recent 5 years available.

When did Medtronic EBITDA hit its highest annual value?

Medtronic EBITDA reached its highest annual value of $9.46B in 2018.

What was Medtronic EBITDA in 2024?

Medtronic (MDT) EBITDA in 2024 was $8.20B.

What was Medtronic EBITDA in 2025?

Medtronic (MDT) EBITDA in 2025 was $9.22B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.